NCT03926442

Brief Summary

The objectives of this study are:

  1. 1.To characterize the time course of herbs/spice action on endothelial function as measured by FMD over 24 h using a challenge meal paradigm.
  2. 2.To assess effects of herbs/spices on metabolic indices (ie., glucose, insulin), and inflammatory markers such as cytokines (ie., IL-6, TNF-alpha) and vascular adhesion molecules (ICAM and VCAM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 18, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 19, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

July 27, 2021

Status Verified

July 1, 2021

Enrollment Period

1.8 years

First QC Date

April 19, 2019

Last Update Submit

July 26, 2021

Conditions

Keywords

SpicesHerbsMetabolic responsesEndothelial functionInflammatory markers

Outcome Measures

Primary Outcomes (1)

  • Changes in postprandial endothelial function among 4 treatments measured in percent flow mediated dilation

    Vascular Assessments will be measured with Flow mediated vasodilation (FMD)

    Baseline to 24 hours

Secondary Outcomes (5)

  • Changes in Plasma Interleukin-1 β (IL-1β) concentration response among 4 treatments.

    Baseline to 24 hours

  • Changes in Plasma Interleukin-6 (IL-6) concentration response among 4 treatments.

    Baseline to 24 hours

  • Changes in Plasma Tumor Necrosis Factor-α (TNF-α) concentration response among 4 treatments.

    Baseline to 24 hours

  • Changes in Plasma intercellular adhesion molecule 1 (ICAM 1) concentration response among 4 treatments.

    Baseline to 24 hours

  • Changes in Plasma vascular cell adhesion molecule 1 (VCAM 1) concentration response among 4 treatments.

    baseline to 24 hours

Study Arms (4)

Active1

EXPERIMENTAL

Italian Herb in active breakfast meal

Other: Italian Herb meal

Active2

EXPERIMENTAL

Cinnamon in active breakfast meal

Other: Cinnamon Meal

Active3

EXPERIMENTAL

Pumpkin Spice Mix in active breakfast meal

Other: Pumpkin Spice meal

Placebo Comparator

PLACEBO COMPARATOR

Placebo Breakfast

Other: Placebo meal

Interventions

Italian Herb in active breakfast meal

Also known as: Italian Herb
Active1

Cinnamon in active breakfast meal

Also known as: Cinnamon
Active2

Pumpkin Spice Mix in active breakfast meal

Also known as: Pumpkin Spice Mix
Active3

Placebo in breakfast meal

Also known as: Placebo
Placebo Comparator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI between 25 and 35 kg/m2
  • Aged 18 years and older
  • Able to provide informed consent and comply with study procedures
  • Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial.
  • Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests.
  • People with no documented disease condition that would interfere with the study endpoints (ie., CVD, diabetes, hypertension, major organ diseases) or taking medication or dietary supplements that may interfere with study endpoints

You may not qualify if:

  • Current smoker or marijuana user
  • No history or presence of atherosclerosis/cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders that may interfere with study outcomes.
  • Taking any medications and/or supplements that would interfere with outcomes of the study (i.e., lipid-lowering medications, anti-inflammatory drugs, etc)
  • Unstable use of any medication/supplement, this could include marijuana used as -needed for medical reasons
  • Have a history of cancer, except for non-melanoma skin cancer in past 5 years
  • Addicted to drugs and/or alcohol (\>4 drinks/day)
  • Have been exposed to any non-registered drug product within last 30 days.
  • Working overnight (e.g. 3rd shift of overnight workers)
  • Excessive exercisers or trained athletes
  • Have allergies/intolerances to cinnamon, Italian herbs, etc.
  • Extreme dietary habits (ie. vegetarian/vegan)
  • Excessive coffee/tea drinker (\>4 cups/day)
  • Actively losing weight/ trying to lose weight (unstable body weight fluctuations of \> 5 kg in 3 months)
  • Donated blood within last 3 months
  • Female who is pregnant, planning to be pregnant, breastfeeding
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Nutrition Research Center

Chicago, Illinois, 60616, United States

Location

Related Publications (2)

  • Huang Y, Edirisinghe I, Burton-Freeman BM, Sandhu AK. Characterization and Pharmacokinetic Profile of Herbs and Spices' Phytochemicals over 24 h after Consumption in Overweight/Obese Adults. Mol Nutr Food Res. 2023 Jul;67(14):e2200785. doi: 10.1002/mnfr.202200785. Epub 2023 Jun 13.

  • Huang Y, Tsai MF, Thorat RS, Xiao D, Zhang X, Sandhu AK, Edirisinghe I, Burton-Freeman BM. Endothelial Function and Postprandial Glucose Control in Response to Test-Meals Containing Herbs and Spices in Adults With Overweight/Obesity. Front Nutr. 2022 Feb 22;9:811433. doi: 10.3389/fnut.2022.811433. eCollection 2022.

Study Officials

  • Britt Burton-Freeman, Ph.D

    Illinois Institute of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2019

First Posted

April 24, 2019

Study Start

April 18, 2019

Primary Completion

February 1, 2021

Study Completion

February 1, 2021

Last Updated

July 27, 2021

Record last verified: 2021-07

Locations